Valdés R - Search Results

1

E2-CD154 vaccine candidate is safe and immunogenic in pregnant sows, and the maternal derived neutralizing antibodies protect piglets from classical swine fever virus challenge.

Pérez-Pérez D, Sordo-Puga Y, Rodríguez-Moltó MP, Sardina T, Santana E, Montero C, Ancizar J, Cabrera Y, Tuero Á, Naranjo P, Sosa-Testé I, Fernandez F, Valdés R, Duarte CA, Suárez-Pedroso M. Pérez-Pérez D, et al. Among authors: valdes r. Vet Microbiol. 2021 Sep;260:109153. doi: 10.1016/j.vetmic.2021.109153. Epub 2021 Jun 16. Vet Microbiol. 2021. PMID: 34271304

2

Humoral and cellular immune response in mice induced by the classical swine fever virus E2 protein fused to the porcine CD154 antigen.

Sordo Y, Suárez M, Caraballo R, Sardina T, Brown E, Duarte C, Lugo J, Gil L, Perez D, Oliva A, Vargas M, Santana E, Valdés R, Rodríguez MP. Sordo Y, et al. Among authors: valdes r. Biologicals. 2018 Mar;52:67-71. doi: 10.1016/j.biologicals.2017.12.004. Epub 2018 Jan 5. Biologicals. 2018. PMID: 29311002

3

Multiepitope polypeptide of the HIV-1 envelope induces neutralizing monoclonal antibodies against V3 loop.

Duarte CA, Montero M, Seralena A, Valdés R, Jiménez V, Benítez J, Narciandi E, Madrazo J, Padrón G, Sánchez G, et al. Duarte CA, et al. Among authors: valdes r. AIDS Res Hum Retroviruses. 1994 Mar;10(3):235-43. doi: 10.1089/aid.1994.10.235. AIDS Res Hum Retroviruses. 1994. PMID: 7517147

4

Epitope mapping, V-region DNA sequence, and neutralizing Fab fragments of two monoclonal antibodies against the HIV-1 V3 loop.

Duarte CA, Pérez L, Vázquez J, Dueñas M, Vilarrubia OL, Navea L, Valdés R, Reyes O, Montero M, Ayala M, Gavilondo J. Duarte CA, et al. Among authors: valdes r. Immunotechnology. 1996 Feb;2(1):11-20. doi: 10.1016/1380-2933(95)00024-0. Immunotechnology. 1996. PMID: 9373324

5

Production and characterization of a chimeric antigen, based on nucleocapsid of SARS-CoV-2 fused to the extracellular domain of human CD154 in HEK-293 cells as a vaccine candidate against COVID-19.

Lao T, Avalos I, Rodríguez EM, Zamora Y, Rodriguez A, Ramón A, Alvarez Y, Cabrales A, Andújar I, González LJ, Puente P, García C, Gómez L, Valdés R, Estrada MP, Carpio Y. Lao T, et al. Among authors: valdes r. PLoS One. 2023 Sep 26;18(9):e0288006. doi: 10.1371/journal.pone.0288006. eCollection 2023. PLoS One. 2023. PMID: 37751460 Free PMC article.

6

Production and biochemical characterization of the recombinant Boophilus microplus Bm95 antigen from Pichia pastoris.

Boué O, Farnós O, González A, Fernández R, Acosta JA, Valdés R, González LJ, Guanche Y, Izquierdo G, Suárez M, Domínguez I, Machado H, Rodríguez M, Lleonart R. Boué O, et al. Among authors: valdes r. Exp Appl Acarol. 2004;32(1-2):119-28. doi: 10.1023/b:appa.0000018199.87122.e4. Exp Appl Acarol. 2004. PMID: 15139278

7

A rapid and sensitive ELISA to quantify an HBsAg specific monoclonal antibody and a plant-derived antibody during their downstream purification process.

Leyva A, Franco A, González T, Sánchez JC, López I, Geada D, Hernández N, Montañés M, Delgado I, Valdés R. Leyva A, et al. Among authors: valdes r. Biologicals. 2007 Mar;35(1):19-25. doi: 10.1016/j.biologicals.2005.12.004. Epub 2006 Feb 23. Biologicals. 2007. PMID: 16500116

8

Prolonged stability of the plantibody HB-01 directed against the hepatitis B surface antigen in cryo-preserved tobacco leaves.

Ferro W, Geada D, Guevara Y, Padilla S, Conde A, Alvarez T, Medina Y, González T, Wood M, Valdés R. Ferro W, et al. Among authors: valdes r. Biologicals. 2010 May;38(3):415-9. doi: 10.1016/j.biologicals.2010.02.011. Epub 2010 Mar 19. Biologicals. 2010. PMID: 20303783

9

Validation of model virus removal and inactivation capacity of an erythropoietin purification process.

Pérez M, Rodríguez E, Rodríguez M, Paez R, Ruibal I, Noa E, García O, Moya G, Martínez M, Marcelo J, Martínez A, Dubal M, Navea L, Valdés R. Pérez M, et al. Among authors: valdes r. Biologicals. 2011 Nov;39(6):430-7. doi: 10.1016/j.biologicals.2011.09.006. Epub 2011 Oct 8. Biologicals. 2011. PMID: 21982851

10

Application of a risk analysis method to different technologies for producing a monoclonal antibody employed in hepatitis B vaccine manufacturing.

Milá L, Valdés R, Tamayo A, Padilla S, Ferro W. Milá L, et al. Among authors: valdes r. Biologicals. 2012 Mar;40(2):118-28. doi: 10.1016/j.biologicals.2011.12.004. Epub 2012 Jan 28. Biologicals. 2012. PMID: 22285820

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

297 results

Search Page